Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2023-02-23
2025-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention to Change Affect Recognition and Empathy
NCT05636020
Online Emotional Regulation Group Treatment
NCT01730261
Online Emotion Regulation Group Intervention
NCT03479606
Community-based Implementation of Online EmReg
NCT05933629
Online Intervention for Traumatic Brain Injury Wellbeing
NCT05115656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes.
Treatment
8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment
8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥18 years old
* U.S. resident (exclusion for California residents)
* ≥6 months post-TBI
* elevated alexithymia and emotion dysregulation (defined by \>.5 standard deviation above means on the TAS-20 and DERS)
* capacity to consent
* proficient English
* if on medications that influence affect, must be stable for at least 6 weeks
* access to a device capable of video conferencing and high speed internet.
Exclusion Criteria
* degenerative neurologic condition
* visual, hearing, communication, or cognitive impairments that would impede participation
* unstable or anticipated medication changes that will influence mood/ affect during study participation
* active involvement in an intensive rehabilitation program
* individuals who recently started psychotherapy (e.g., \< 3 months ago)
* participant behaviors that cause concern for their ability to participate in accordance with the study requirements and protocol (e.g., unreliable correspondences, no-shows, no-replies to multiple contacts, habitual rescheduling, unable to complete study requirements in timely manner)
* concurrent participation in any other clinical trial that aims to improve mood/ behavioral functioning will be an exclusion criterion.
* participants will be excluded if at any point, they participated in TREAT (in-person clinical trial of BEST - NCT03414463)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Intrepid Center of Excellence
FED
Congressionally Directed Medical Research Programs
FED
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Flora Hammond
Chair of Department of Physical Medicine and Rehabilitation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Flora Hammond, MD
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
W81XWH-22-2-0064
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
15355
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.